Eli Lilly and

NYSE: LLY · Real-Time Price · USD
689.37
4.94 (0.72%)
At close: Aug 15, 2025, 9:58 AM

Eli Lilly and Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Revenue
45.04B 34.12B 28.54B 28.32B
Cost of Revenue
8.42B 7.08B 6.63B 7.31B
Gross Profit
36.62B 27.04B 21.91B 21.01B
Operating Income
17.5B 10.79B 8.65B 7.93B
Interest Income
175.2M 173.6M 62.8M 25.4M
Pretax Income
12.68B 6.55B 6.81B 6.16B
Net Income
10.59B 5.24B 6.24B 5.58B
Selling & General & Admin
8.13B 6.94B 6.07B 6.14B
Research & Development
10.99B 9.31B 7.19B 6.93B
Other Expenses
n/a n/a n/a n/a
Operating Expenses
19.12B 16.25B 13.26B 13.07B
Interest Expense
780.6M 485.9M 331.6M 339.8M
Selling & Marketing Expenses
n/a n/a n/a n/a
Cost & Expenses
27.54B 23.34B 19.89B 20.39B
Income Tax Expense
2.09B 1.31B 561.6M 573.8M
Shares Outstanding (Basic)
900.61M 899.38M 950.18M 953.65M
Shares Outstanding (Diluted)
904.06M 903.28M 950.18M 953.65M
EPS (Basic)
11.76 5.83 6.57 5.85
EPS (Diluted)
11.71 5.80 6.57 5.85
EBITDA
15.23B 8.57B 8.66B 8.04B
EBIT
13.46B 7.04B 7.14B 6.5B
Depreciation & Amortization
1.77B 1.53B 1.52B 1.55B